newsfilter
← Latest News
PR Newswire·

Provention Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

RED BANK, N.J., Feb. 24, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results for the fourth quarter and full year ended D